In 2023, the standard vaccination strategy for children and adolescents was updated. The human papillomavirus vaccine (HPV) was changed from the age of 12 to 11, and the interval between vaccinations for the Japanese encephalitis vaccine also changed. On the 24th, the Korean Vaccine Society held the 21st Spring Conference at L Convention and shared … Read more
Biktarvy product photo Five-year long-term data of the HIV-1 drug Biktarvy (ingredient name bictegravir/emtricitabine/tenofovir alafenamide, B/F/TAF) was added to the approval requirements. Gilead Sciences Korea announced on the 27th that the Ministry of Food and Drug Safety on January 30th added clinical information on 5-year long-term data conducted on adults infected with HIV-1 after initial … Read more
Lee Han-ah, planning committee member of the Liver Cancer Association (Division of Gastroenterology, Ewha Womans University Mok-dong Hospital) While the number of elderly patients with liver cancer is increasing, a study has found that the prognosis during treatment intervention is similar to that of non-elderly patients. In particular, in the case of advanced liver cancer … Read more
Cancer, not cardiovascular disease, is the leading cause of death in type 2 diabetes, a new study has found. This breaks the conventional wisdom that the cause of death in diabetes is a cardiovascular disease complication, suggesting the need for a multidisciplinary approach. The results of a study on the mortality rate of patients with … Read more
Daewoong Pharmaceutical announced that Enblo Tab. was announced as a successful case of rapid product development at the ‘Innovative Pharmaceutical Company GIFT Rapid Review Support Conference’ co-hosted by the Rapid Review Division of the Food and Drug Safety Evaluation Institute and the Korea Pharmaceutical Bio Association at 3:00 pm on the 26th. . An innovative … Read more
The side effect issue of diabetic retinopathy (DR) of type 2 diabetes treatment glucagon-like peptide-1 receptor agonist (GLP-1 RA) has been reconfirmed. At the time of the development of semaglutide, an increase in retinopathy patients was observed in clinical trials, but as a similar trend was found in a meta-analysis involving a total of 60,000 … Read more
Studies have shown that high-density lipoprotein (HDL-C), the cholesterol that is good for cardiovascular health, is negative for bone health. For cardiovascular health, high HDL-C is good, but for bone health, it means you need to find the right trade-off. The results of a study on the association between plasma HDL-C levels and fracture risk, … Read more
Paljinhoe, a representative meeting of pharmaceutical industry elders, has ended its 48-year partnership. Paljinhoe is a friendly gathering founded in 1975 by eight owners and executives of major domestic pharmaceutical companies with the intention of “let’s go forward together as eight people”. The Paljinhoe, a meeting of pharmaceutical industry elders, concluded the 48-year-old meeting on … Read more
Crystal Genomics announced on the 22nd that it will participate in the “2023 JP Morgan Healthcare Conference” and Biotech Showcase held in San Francisco, USA, and present its R&D status. Crystal Genomics logo Crystal Genomics will simultaneously participate in the “JP Morgan Healthcare Conference” which will be held in San Francisco, USA for four days … Read more
Clinical results have shown that older brains whose artificial intelligence (AI) predicted age is higher than their actual age are 150% more likely to suffer from dementia. On the 15th, the team led by Professor Chang-Hyung Hong, Sang-Jun Son and Hyun-Woong Noh of the Department of Psychiatry of Ajou University Hospital conducted a joint study … Read more